Drugs / Allogeneic Microbiota
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06321536 | Jan 2025 → Jul 2026 overdue | — | Emory University | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic Microbiota | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06321536 ↗ |
| Known as | AMG | “Allogeneic Microbiota in Glycerol (9%) (AMG)” NCT06321536 ↗ |
| Modality | Other / unclassified | “microbiota therapy (MT)” NCT06321536 ↗ |
| Route | Rectal | “via rectal enema” NCT06321536 ↗ |